title: Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload.
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Ohashi
authors.forename: Kayo
authors.initials: K
authors.lastname: Arita
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tomita
authors.forename: Tomoki
authors.initials: T
authors.lastname: Naoe
authors.forename: Ai
authors.initials: A
authors.lastname: Hattori
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Tatsumi
authors.forename: Koichi
authors.initials: K
authors.lastname: Kato
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Nagai
mesh_terms: D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed; D065227:Transfusion Reaction; D016896:Treatment Outcome
chemical_list: D007502:Iron Chelating Agents; D007501:Iron